Axela Biosciences provides highly sensitive and multiplex immunoassay services designed to quantify proteins, cytokines, biomarkers, and signaling molecules from minimal sample volumes. Their platforms support drug discovery, translational research, biomarker development, and preclinical studies across oncology, immunology, autoimmune disease, and inflammation research.

Overview

Axela’s immunoassay services utilize multiplex bead-based assays, antibody microarrays, and ultra-sensitive detection technologies to generate high-content biological data from complex sample types. Their workflows are optimized to maximize information while reducing sample consumption and assay variability.

Supported sample types include:

• Serum and plasma
• Cell and tissue lysates
• Cell culture supernatants
• Saliva and urine
• Nasal lavage and exhaled breath condensate
• Exosomes and extracellular vesicles

Core Capabilities

Axela Biosciences offers:

• Multiplex cytokine and chemokine profiling
• Ultra-sensitive biomarker quantification
• Custom immunoassay development
• Luminex and bead-based assays
• Protein phosphorylation analysis
• miRNA and mRNA profiling
• ELISA conversion to multiplex platforms
• Assay validation and optimization

Their assay platforms support both predefined biomarker panels and fully customized panel development tailored to project-specific research goals.

Platform & Technical Expertise

Axela leverages advanced immunoassay technologies including:

• Luminex FlexMAP3D and Luminex 200
• SIMOA ultra-sensitive detection
• AlphaLISA and HTRF platforms
• Protein microarrays
• ELISA and multiplex bead arrays

Their scientific team provides support for assay design, validation, biomarker selection, and data analysis to accelerate translational and therapeutic development programs.

Applications

Immunoassay services are commonly used for:

• Cytokine profiling
• Biomarker discovery
• Immune monitoring
• Drug response analysis
• Translational biomarker programs
• Inflammation and autoimmune research
• Oncology and immuno-oncology studies
• Preclinical and clinical assay development